IT1317067B1 - Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. - Google Patents

Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.

Info

Publication number
IT1317067B1
IT1317067B1 IT2000RM000626A ITRM20000626A IT1317067B1 IT 1317067 B1 IT1317067 B1 IT 1317067B1 IT 2000RM000626 A IT2000RM000626 A IT 2000RM000626A IT RM20000626 A ITRM20000626 A IT RM20000626A IT 1317067 B1 IT1317067 B1 IT 1317067B1
Authority
IT
Italy
Prior art keywords
allergic
shock
vegetable origin
histaminas
espectic
Prior art date
Application number
IT2000RM000626A
Other languages
English (en)
Inventor
Bruno Mondovi
Olivia Befani
Rodolfo Federico
Mircea Alexandru Mateescu
Emanuela Masini
Pier Francesco Mannaioni
Alfredo Vannacci
Original Assignee
Univ Roma
Univ Degli Studi Roma Tre
Univ Quebec Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Roma, Univ Degli Studi Roma Tre, Univ Quebec Montreal filed Critical Univ Roma
Publication of ITRM20000626A0 publication Critical patent/ITRM20000626A0/it
Priority to IT2000RM000626A priority Critical patent/IT1317067B1/it
Priority to CA002430291A priority patent/CA2430291A1/en
Priority to US10/433,075 priority patent/US20040115189A1/en
Priority to EP01998357A priority patent/EP1339422B1/en
Priority to AT01998357T priority patent/ATE349222T1/de
Priority to DE60125585T priority patent/DE60125585D1/de
Priority to PCT/EP2001/013770 priority patent/WO2002043745A2/en
Priority to AU2002221897A priority patent/AU2002221897A1/en
Publication of ITRM20000626A1 publication Critical patent/ITRM20000626A1/it
Application granted granted Critical
Publication of IT1317067B1 publication Critical patent/IT1317067B1/it
Priority to US12/217,447 priority patent/US8722038B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03022—Diamine oxidase (1.4.3.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IT2000RM000626A 2000-11-29 2000-11-29 Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. IT1317067B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT2000RM000626A IT1317067B1 (it) 2000-11-29 2000-11-29 Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
AT01998357T ATE349222T1 (de) 2000-11-29 2001-11-27 Histaminase pflanzlichen ursprungs zur behandlung von allergischem und septischem schock und allergischem asthma
US10/433,075 US20040115189A1 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
EP01998357A EP1339422B1 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
CA002430291A CA2430291A1 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
DE60125585T DE60125585D1 (de) 2000-11-29 2001-11-27 Histaminase pflanzlichen ursprungs zur behandlung von allergischem und septischem schock und allergischem asthma
PCT/EP2001/013770 WO2002043745A2 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
AU2002221897A AU2002221897A1 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
US12/217,447 US8722038B2 (en) 2000-11-29 2008-07-03 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000626A IT1317067B1 (it) 2000-11-29 2000-11-29 Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.

Publications (3)

Publication Number Publication Date
ITRM20000626A0 ITRM20000626A0 (it) 2000-11-29
ITRM20000626A1 ITRM20000626A1 (it) 2002-05-29
IT1317067B1 true IT1317067B1 (it) 2003-05-26

Family

ID=11455023

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000626A IT1317067B1 (it) 2000-11-29 2000-11-29 Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.

Country Status (8)

Country Link
US (2) US20040115189A1 (it)
EP (1) EP1339422B1 (it)
AT (1) ATE349222T1 (it)
AU (1) AU2002221897A1 (it)
CA (1) CA2430291A1 (it)
DE (1) DE60125585D1 (it)
IT (1) IT1317067B1 (it)
WO (1) WO2002043745A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502098B8 (de) * 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
WO2012028891A1 (en) * 2010-09-02 2012-03-08 Debreceni Egyetem Perorally applicable preparation containing histaminase of vegetable origin, resistant to pepsin and trypsin and a process for producing it
ES2388515B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para la prevención de los síntomas de la resaca.
ES2388395B1 (es) 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica.
ES2387973B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
CA2831535C (en) 2011-04-07 2014-10-21 Histapharm Inc. Oral enzyme compositions for intestinal delivery
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
US20220145269A1 (en) 2019-02-19 2022-05-12 Medizinische Universität Wien New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6815177A (it) * 1968-10-24 1970-04-28
FR2101095A1 (en) * 1970-08-20 1972-03-31 Merieux Inst Diamine oxidase from human placenta - for treatment of hyperhistamina
FR2215944A1 (en) * 1973-02-01 1974-08-30 Bellon Labor Sa Roger Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies
US4725540A (en) * 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
JPH0698026B2 (ja) * 1987-12-28 1994-12-07 東洋紡績株式会社 ポリアミンの測定法
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
US5324510A (en) * 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
GB9715203D0 (en) * 1997-07-19 1997-09-24 Piper Edwina M Composition

Also Published As

Publication number Publication date
CA2430291A1 (en) 2002-06-06
US8722038B2 (en) 2014-05-13
DE60125585D1 (de) 2007-02-08
ITRM20000626A0 (it) 2000-11-29
AU2002221897A1 (en) 2002-06-11
ITRM20000626A1 (it) 2002-05-29
WO2002043745A2 (en) 2002-06-06
WO2002043745A3 (en) 2003-04-10
EP1339422A2 (en) 2003-09-03
EP1339422B1 (en) 2006-12-27
ATE349222T1 (de) 2007-01-15
US20080279840A1 (en) 2008-11-13
US20040115189A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
WO2001056466A3 (en) Method for evaluating novel stroke treatments using a tissue risk map
MXPA03003823A (es) Metodo y aparato para el tratamiento de agua y aguas negras.
MXPA03001268A (es) Ariloxipiperidinas sin imidazol.
IT1317067B1 (it) Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
NO20081615L (no) Fremgangsmater for a forbedre avvanningsevnen til slam med a-amylasebehandling
MY180733A (en) Method of using ?-hydroxy-?-methybutyrate
MX2009001342A (es) Composiciones y metodos para el tratamiento de proctosigmoiditis por radiacion.
WO2004101889A8 (en) Use of hemicellulase composition in mechanical pulp production
UA96164C2 (ru) Процесс обработки сточного ила
ATE440169T1 (de) Fluorchemisch oligomere zusammensetzung und deren verwendung
GB0308952D0 (en) Method
ATE524420T1 (de) Schlammbehandlung bei mesophiler temperatur
EP1598122A4 (en) PROCESS FOR TREATING ORGANIC WASTE, AGENT FOR TREATING ORGANIC WASTE AND MICROORGANISMS FOR USE THEREFOR
SE0301773L (sv) Alkaliska extraktionssteg vilka innefattar xylanas
EA200401032A1 (ru) Антиинфарктные молекулы
WO2003045848A3 (de) Mikrobiologische energiequelle zum antrieb eines verbrauchers
AU2003225406A8 (en) Method of improving material comprising a pozzolanic component
RU2005133891A (ru) Способ очистки стоков
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
PT1392606E (pt) Processo para a purificacao de agua proveniente de uma instalacao de dessulfuracao de querosene
CN105770948A (zh) 含有红螺菌和放线菌的生物除臭剂
ATE385434T1 (de) Verfahren und vorrichtung zur behandlung von verunreinigtem wasser
DE60303517D1 (de) 100% öl-oberflächenbehandlungszusammensetzung und damit behandelte faseriges garn
KR970006195A (ko) 소석회를 이용한 불소함유 폐수의 처리방법
HK1057392A1 (en) Method for improving properties of combustion residues produced by combustion plant, and method for treatment of the residues